---
created: 2025-04-13
updated: 2025-04-13T10:53
id: JS4~OQ]M51
specialty: pharmaco
specialty_id: 347
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::14-msk::03-pathology::07-gout-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::09-gout-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::09-gout-drugs::acute::nsaids
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::09-gout-drugs::chronic::probenecid
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::02-metabolism
  - "source/ak-step1-v11:": 
  - theme/physeo::05-biochem::05-metabolism::18-purines-&-pyrimidines
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::09-musculoskeletal::02-aspirin
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::09-musculoskeletal::08-acute-and-chronic-gout-treatment
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::02-pathways::10-purine-excretion
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::12-msk::probenecid
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::03-anti-inflammatory::02-gout-drugs::zanki-extra
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
**Probenecid** and **high**-dose Aspirin decrease renal tubular **reabsorption** of uric acid

---

# Answer
- This is predominantly done by inhibiting the URAT channels on the apical tubular membrane   - URAT is an antiporter, excreting organic anion (eg, lactate) in exchange for reabsorbing uric acid